Gynecologic Oncology Revenue Cycle Management

Specialty Billing Built for Gynecologic Oncology Practices

Gynecologic oncology billing hinges on radical hysterectomy bundling, lymphadenectomy add-ons, and a parallel chemotherapy administration ladder with J-code waste reporting. Add 90-day global periods on radical surgery and prior auth on biologics, and general billers miss revenue on every case. MedFactor delivers gyn-onc-specific RCM that protects every claim.

HIPAA Compliant AAPC Certified Coders Nationwide Support Gyn-Onc Specialists
Surgery + Chemo — RCM PanelLive
Procedure Bundle Tracker
Radical hysterectomy + pelvic nodes
Base surgical procedure
58210
Chemo IV infusion — first hour
Chemotherapy administration base
96413
Chemo IV infusion — each addl hour
Add-on hour, same session
96415
Discarded drug waste — JW
Separately reportable
JW
0%
Clean Claim Rate
0%
Denial Reduction
0d
Days in A/R
Subspecialty Expertise

Gyn-Onc Practice Types We Support

From ovarian and cervical cancer to complex pelvic surgery, we tailor billing to the coding rules of every gynecologic oncology subspecialty.

Ovarian

Ovarian Cancer

Cytoreductive surgery, omentectomy (58943), debulking with lymphadenectomy, and intraperitoneal chemotherapy administration coding.

Cervical

Cervical Cancer

Radical hysterectomy (58210/58200), pelvic lymph node dissection (38770), and chemoradiation coordination with appropriate bundling.

Endometrial / Uterine

Endometrial & Uterine Cancer

Total laparoscopic hysterectomy (58570/58571), staging lymphadenectomy, and sentinel node biopsy coding accuracy.

Vulvar / Vaginal

Vulvar & Vaginal

Radical vulvectomy, partial vulvectomy, and inguinal lymphadenectomy with proper staged-procedure modifier 58 usage.

Trophoblastic

Gestational Trophoblastic

Hydatidiform mole evacuation, low-dose methotrexate chemotherapy tracking, and hCG-based follow-up E/M coding.

Complex Pelvic

Complex Pelvic Surgery

Exenterative procedures, urinary diversion, pelvic reconstruction, and modifier 22 for increased procedural service.

The Defining Complexity

Radical Surgery + Chemotherapy Administration Ladder

Gynecologic oncology uniquely runs two billing tracks in parallel: a radical-surgery base with lymphadenectomy and omental add-ons, and a chemotherapy administration hierarchy (first hour, each additional hour, hydration, non-chemo IV) with J-code drug waste reported separately on JW. This dual-track complexity is the largest source of gyn-onc denials and leakage.

Radical Surgery Base + Lymphadenectomy Add-Ons + Parallel Chemo Ladder + JW Waste

One surgical session bills a radical hysterectomy base with lymph node and omental add-ons, while a separate chemotherapy encounter bills the administration hierarchy with discarded drug waste on the JW modifier.

Track 1 — Radical Surgery
Base Procedure
Radical abdominal hysterectomy with pelvic lymphadenectomy
58210
Retroperitoneal lymph node dissection
Para-aortic lymphadenectomy add-on, staging
38770
Omentectomy / peritoneal biopsy
Omental staging biopsy, ovarian cancer
58943
Bilateral salpingo-oophorectomy (separate, mod 51)
Distinct procedure, same session
58953 · 51
Track 2 — Chemotherapy Administration Ladder
Base Administration
Chemotherapy IV infusion, first hour
96413
Chemo IV infusion, each additional hour
Add-on hour, same session
96415
Hydration IV infusion, first hour
Pre/post hydration support
96521
Non-chemo drug IV infusion, first hour
Supportive / antiemetic infusion
96365
Discarded drug waste (JW)
Separately reportable — e.g. J9170 docetaxel waste
JW
Our focus: We sequence the radical hysterectomy as the surgical base, add para-aortic lymphadenectomy and omentectomy as distinct add-ons, and bill BSO with modifier 51 where required. For chemotherapy, we bill 96413 as the first-hour base, 96415 for each additional hour, 96521 for hydration, and 96365 for non-chemo IV infusions — and report discarded single-use vial waste on the JW modifier so the practice is paid for every unit of administered and wasted drug.
Industry Challenges

Why Gyn-Onc Practices Lose Revenue

Gynecologic oncology billing is governed by radical-surgery bundling, the chemo administration hierarchy, and J-code waste rules that general billing companies cannot navigate effectively.

Complex Surgery Bundling

Radical hysterectomy add-ons (lymphadenectomy, omentectomy) dropped or denied as bundled when billed without correct sequencing and modifiers.

Severity

Chemo Administration Hierarchy

96413 first-hour, 96415 add-on hours, and hydration/non-chemo codes mis-sequenced, losing the first-hour base and add-on-hour revenue.

Severity

J-Code Waste / JW Not Reported

Discarded single-use vial drug waste (JW modifier) not reported, forfeiting reimbursement for wasted chemotherapy units.

Severity

90-Day Global on Radical Surgery

Post-operative visits within the 90-day global of radical hysterectomy billed separately and denied, or missed opportunity for modifier 22 complexity.

Severity

Modifier 25 with Global Procedures

Same-day E/M with a procedure in the global period denied without modifier 25 supporting a significant, separately identifiable service.

Severity

Prior Auth on Biologics / Chemo

High-cost biologics and chemotherapy agents denied for missing or expired prior authorization, delaying infusion and losing revenue.

Severity
Code Reference

Common Gynecologic Oncology Billing Codes

Quick reference for the most frequently used codes in gynecologic oncology billing and coding.

CPT / HCPCS
ICD-10 Codes
Modifiers
CodeDescriptionCommon Use
58210Radical abdominal hysterectomy with bilateral pelvic lymphadenectomyCervical cancer base surgery
58200Radical hysterectomy with pelvic & para-aortic lymphadenectomyExtended radical surgery
58550Laparoscopic-assisted radical hysterectomyMinimally invasive radical hyst
38530Biopsy, lymph node (open)Lymph node sampling
38770Retroperitoneal lymph node dissectionPara-aortic lymphadenectomy add-on
58940Resection of ovarian tumorOvarian mass / tumor excision
58943Omentectomy, total or partialOvarian cancer staging
58953BSO with omentectomy, total abdominal hysterectomyOvarian debulking surgery
96413Chemotherapy IV infusion, first hourChemo administration base
96415Chemotherapy IV infusion, each additional hourChemo add-on hour
96521Hydration IV infusion, first hourPre/post chemo hydration
96365IV infusion, non-chemo drug, first hourSupportive / antiemetic infusion
J9170Docetaxel 1 mg (HCPCS J-code)Chemo drug supply
CodeDescriptionClinical Context
C53.xMalignant neoplasm of cervix uteriCervical cancer
C54.xMalignant neoplasm of corpus uteriEndometrial / uterine cancer
C56.xMalignant neoplasm of ovaryOvarian cancer
C51.xMalignant neoplasm of vulvaVulvar cancer
C52Malignant neoplasm of vaginaVaginal cancer
C58Malignant neoplasm of placentaGestational trophoblastic
D07.xCarcinoma in situ of cervix / endometriumPre-invasive CIN / FIGO 0
Z51.11Encounter for antineoplastic chemotherapyChemo encounter
Z12.72Encounter for screening for malignant neoplasm of ovaryBRCA / high-risk screening
Z85.42Personal history of malignant neoplasm of ovarySurveillance follow-up
ModifierDescriptionGyn-Onc Application
25Separate E/M same dayE/M with same-day procedure in global period
50Bilateral procedureBilateral lymph node dissection, BSO
51Multiple proceduresBSO with radical hysterectomy same session
59Distinct procedural serviceDistinct lymph node / omental procedures same session
22Increased procedural serviceUnusually complex radical surgery / exenteration
26Professional componentRadiation / imaging interpretation
TCTechnical componentImaging / facility technical portion
JWDiscarded drug wasteDiscarded single-use chemo vial waste
Our Services

End-to-End Gyn-Onc RCM Solutions

Comprehensive revenue cycle management designed specifically for gynecologic oncology practices.

Gyn-Onc Billing & Coding

Specialty coders handle radical hysterectomy bundling, lymphadenectomy add-ons, chemo administration hierarchy, and JW waste reporting with accuracy.

Denial Management & Appeals

Surgery bundling defense, chemo administration hierarchy corrections, and J-code waste appeals with procedural documentation for gyn-onc denials.

Prior Authorization

Pre-infusion authorization for high-cost biologics, chemotherapy agents, and complex radical surgery procedures.

A/R Recovery & Follow-Up

Prioritized follow-up on aged radical surgery, chemotherapy, and J-code claims with strategic payer escalation to maximize recovery.

Compliance Auditing

Regular audits focused on chemo administration capture, JW waste reporting, modifier 25/51/59, and 90-day global-period compliance.

Analytics & Reporting

Real-time dashboards tracking radical-surgery volume, chemo administration units, and J-code waste capture by payer.

Top Denial Categories

Where Gyn-Onc Revenue Leaks

Understanding the most common denial reasons is the first step to preventing them on radical surgery, chemotherapy, and J-code claims.

Surgery Add-On Denials

Lymphadenectomy and omentectomy denied as bundled into radical hysterectomy when billed without correct sequencing and modifiers.

Our Fix

Add-on sequencing with modifier 51/59 for distinct procedures same session.

Chemo Administration Hierarchy Denials

96413 first-hour base and 96415 add-on hours mis-sequenced, losing the first-hour and additional-hour revenue.

Our Fix

Correct administration ladder with 96413 base, 96415 add-on hours, and hydration/non-chemo separation.

J-Code Waste / JW Denials

Discarded single-use vial waste not reported on the JW modifier, forfeiting reimbursement for wasted chemo units.

Our Fix

JW modifier reporting on every discarded unit with documented waste log.

Biologic / Chemo Prior-Auth Denials

High-cost biologics and chemotherapy agents denied for missing or expired prior authorization.

Our Fix

Pre-infusion prior auth verification with payer-specific criteria tracking.

Revenue Leakage

Where Gyn-Onc Practices Lose Money

Identifying and plugging these common revenue leakage points can significantly improve your practice's bottom line.

Surgery Add-Ons Dropped

Lymphadenectomy and omentectomy not billed as add-ons to radical hysterectomy.

Chemo Hours Lost

96415 additional-hour infusions not billed when the first-hour 96413 is captured.

JW Waste Unreported

Discarded single-use vial waste not reported, losing reimbursement on wasted chemo units.

Global-Period Visits

Modifier 22 for unusually complex radical surgery not applied, losing complexity-based revenue.

The Difference

Without vs. With MedFactor

See how gyn-onc-specific revenue cycle management transforms your practice's financial performance.

Without Specialty RCM

  • Lymphadenectomy and omentectomy denied as bundled into radical hysterectomy
  • 96415 additional-hour chemo infusions not billed with the 96413 base
  • Discarded single-use vial waste never reported on the JW modifier
  • 90-day global visits billed separately and denied as global-period
  • Same-day E/M with a procedure denied without modifier 25 support
  • High-cost biologics and chemo agents denied for missing prior auth
  • No visibility into chemo administration units or J-code waste capture

With MedFactor Gyn-Onc RCM

  • Every lymphadenectomy and omentectomy billed as the correct add-on
  • 96413 first-hour base with 96415 add-on hours on every infusion
  • JW modifier reported on every discarded unit with waste documentation
  • 90-day global tracked with modifier 22 applied for complex surgery
  • Modifier 25 supported with significant, separately identifiable E/M notes
  • Pre-infusion prior auth verified before every high-cost agent
  • Real-time dashboards tracking chemo units and J-code waste capture
Onboarding

Your Path to Optimized Revenue

A structured onboarding process designed to deliver measurable improvements within the first 90 days.

1
WEEK 1–2

Discovery & Audit

Review of gyn-onc billing operations, surgery add-on capture, chemo administration, and revenue cycle baseline.

2
WEEK 3–4

Setup & Integration

EMR and infusion-system integration, dedicated gyn-onc billing team, and payer enrollment verification.

3
WEEK 5–8

Go-Live Operations

Full billing with real-time claim submission, modifier verification, and denial prevention protocols.

4
WEEK 9–12

Optimization

Performance review against baseline, workflow optimization, and documented revenue improvement.

Comparison

MedFactor vs. Other Options

How our gyn-onc-specific approach compares to in-house billing and general medical billing companies.

CapabilityIn-House TeamGeneral Billing Co.MedFactor Gyn-Onc
Radical surgery add-on captureInconsistent
Chemo administration hierarchy (96413/96415)
J-code waste (JW) reporting
90-day global-period trackingManualPartial
Modifier 25 with global proceduresInconsistentPartial
Biologic / chemo prior authManualPartial
Modifier 22 for complex surgery
Chemo unit & J-code waste reporting
Dedicated gyn-onc billing team

Why Gyn-Onc Practices Trust MedFactor

Our team combines deep gynecologic oncology billing expertise with the technology and processes to deliver consistent, measurable results for ovarian, cervical, and endometrial cancer programs.

  • AAPC-certified coders with gynecologic oncology and chemotherapy coding experience
  • Dedicated gyn-onc billing teams — no generalists rotating through your account
  • Real-time claim tracking with surgery add-on capture and chemo unit visibility
  • Proven 46% average denial reduction within first 90 days
  • Compliance program aligned with chemo administration hierarchy and JW waste rules
  • Seamless integration with gyn-onc EMR and infusion / pharmacy systems

Get Your Free Gyn-Onc Billing Audit

Discover exactly where your gynecologic oncology practice is losing revenue. Our no-obligation audit analyzes your surgery add-on capture, chemo administration hierarchy, and J-code waste reporting.

  • Radical surgery add-on capture assessment
  • Chemo administration hierarchy review (96413/96415)
  • J-code waste (JW) reporting check
  • 90-day global and modifier 25/22 audit
Schedule Your Free Audit
24%
Average Revenue Improvement
Practices see an average 24% improvement in net collections within the first year.
2 Weeks
Audit Completion Time
Complete billing and coding audit delivered within 10 business days.
Case Studies

Gyn-Onc Practices We've Transformed

Real results from gynecologic oncology practices that partnered with MedFactor for specialty revenue cycle management.

$420K
Revenue Recovered
Ovarian / Surgery + Chemo

Ovarian-Cancer Practice Recovers Surgery & Chemo Revenue

An ovarian-cancer surgery + chemotherapy practice was dropping lymphadenectomy add-ons and mis-sequencing the chemo administration ladder. MedFactor implemented add-on sequencing and the 96413/96415 hierarchy, recovering substantial revenue in eight months.

48%
Denial Reduction
18d
A/R Reduced
$310K
Annual Capture
Cervical / Chemo

Cervical-Cancer Group Fixes JW Waste Reporting

A cervical-cancer group was not reporting discarded single-use vial waste on the JW modifier and losing reimbursement on wasted chemo units. MedFactor implemented JW reporting protocols, recovering waste-based revenue per quarter.

$310K
Annual Recovery
31%
Revenue Increase
+27%
Revenue Increase
Endometrial / Surgery Center

Endometrial Surgery Center Fixes Global-Period Coding

An endometrial surgery center was missing modifier 22 for complex radical hysterectomy and billing global-period visits separately. MedFactor implemented complexity-based modifier protocols that protected surgical and follow-up revenue.

$240K
Annual Savings
27%
Revenue Increase
Nationwide Coverage

Gyn-Onc RCM Across All 50 States

No matter where your gynecologic oncology practice operates, our team understands the payer landscape and regulatory requirements in your region.

Multi-Payer Expertise

Deep coding knowledge across Medicare, Medicaid, and all major commercial payers for gyn-onc services.

Chemo Administration Rules

96413/96415 hierarchy and JW waste reporting applied correctly across all 50 states and payer policies.

Hospital & ASC Alignment

Facility and professional billing coordination across hospital-based radical surgery and infusion suites.

Prior Auth Coverage

State-by-state prior authorization requirements for high-cost biologics and chemotherapy agents.

FAQ

Gyn-Onc Billing Questions Answered

Common questions from gynecologic oncology practices considering MedFactor's specialty RCM services.

How do you bill a radical hysterectomy with multiple add-on procedures?

Radical hysterectomy is billed as one base procedure code plus add-on codes for distinct work performed in the same session. For cervical cancer, 58210 (radical abdominal hysterectomy with bilateral pelvic lymphadenectomy) or 58200 (with para-aortic lymphadenectomy) is the base, with 38770 (retroperitoneal lymph node dissection) and 58943 (omentectomy) as add-ons, and bilateral salpingo-oophorectomy (58953 components) billed with modifier 51 where the payer requires it. We sequence the highest-valued radical surgery code as the base, add each distinct procedure with the correct add-on code, and apply modifier 51 or 59 for legitimately separate procedures — preventing NCCI bundling denials while capturing every component of the surgical session.

How is lymphadenectomy coded with radical hysterectomy?

Pelvic lymphadenectomy is included in the radical hysterectomy base codes 58210 and 58200, so it is not billed separately when performed as part of those procedures. However, para-aortic retroperitoneal lymph node dissection (38770) is billed as an add-on when performed in addition to the pelvic dissection, and open lymph node biopsy (38530) is billed when only a sampling is performed. We verify NCCI edits before submission so lymphadenectomy is coded at the correct level — included in the base when bundled, add-on when extended, and distinct when sampled — preserving the legitimate lymph-node revenue without triggering bundling denials.

How does the chemotherapy administration hierarchy work?

Chemotherapy IV infusion is billed as a hierarchy: 96413 (chemotherapy administration, intravenous infusion, first hour) is the base, and 96415 (each additional hour) is billed for every hour of infusion beyond the first. Hydration is billed separately with 96521 (first hour) when it is the primary service, and non-chemo drug IV infusion uses 96365 (first hour) for supportive agents such as antiemetics. The chemotherapy administration code must be sequenced first when chemo is the primary reason for the encounter. We bill the 96413 first-hour base on every chemo infusion, add 96415 for each additional hour, separate hydration and non-chemo infusions with the correct codes, and append the proper J-code for the drug supply — so every administration hour and every drug unit is captured.

How is J-code drug waste reported?

When a single-use vial of a chemotherapy drug is partially administered and the remainder is discarded, the discarded portion is reported on a separate claim line with the JW (discarded drug) modifier, while the administered portion is billed on its own line with the J-code for the drug (for example J9170 for docetaxel). Medicare and most payers require JW reporting for any discarded amount from a single-use vial so the practice is reimbursed for the wasted units. We log every discarded unit, report it on the JW modifier line with the drug J-code, and keep the waste documentation the payer requires — recovering revenue that most practices lose by billing only the administered dose.

How does the 90-day global period affect radical surgery billing?

Radical hysterectomy (58200/58210) carries a 90-day global period, meaning all routine post-operative visits and related care are bundled into the surgical payment and cannot be billed separately. To capture legitimate additional revenue we track the global period in the practice management system, document modifier 22 (increased procedural service) when the radical surgery is unusually complex — such as extensive adhesions, exenteration, or reconstruction — and bill only services that are genuinely unrelated or staged with the correct modifier (58 for staged, 78 for unplanned return). We do not bill routine global follow-up separately, and we ensure every legitimately billable out-of-global service is captured with the right modifier.

When is modifier 25 used with surgery?

Modifier 25 is appended to an E/M code when a significant, separately identifiable evaluation and management service is performed on the same day as a procedure — for example a pre-operative assessment or a separately documented decision-making visit on the day of a minor procedure or an infusion. Within a 90-day global period, modifier 25 only supports an E/M that is unrelated to the global surgery, so we document the medical necessity and the separate nature of the visit. Without modifier 25, the same-day E/M is denied as bundled into the procedure; without supporting documentation, the modifier 25 claim is denied on audit. We pair every modifier 25 with the supporting note so the E/M is paid rather than denied.

Related Specialties

Explore More RCM Specialties

MedFactor applies the same code-level precision across the full practice spectrum. See how we bill these related specialties.

CPT®, ICD-10, HCPCS, and modifier codes referenced on this page reflect the current code sets and are subject to annual updates — always verify against the current-year fee schedule before submission. KPIs and case-study figures shown are representative benchmarks, not guarantees of individual practice results.

Stop Losing Revenue on Every Radical Surgery & Chemo Cycle

Your gyn-onc practice deserves billing partners who know radical hysterectomy add-on coding, the 96413/96415 administration hierarchy, and JW waste reporting — and code every claim correctly. Let MedFactor show you what specialty RCM can do.

HIPAA Compliant AAPC Certified Nationwide Support

Book An
Appointment